First Time Loading...

Sensyne Health PLC
LSE:SENS

Watchlist Manager
Sensyne Health PLC Logo
Sensyne Health PLC
LSE:SENS
Watchlist
Price: 0.35 GBX -33.33% Market Closed
Updated: May 21, 2024

Sensyne Health PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sensyne Health PLC
Cost of Revenue Peer Comparison

Comparables:
RENX
CRW
IUG
INS
EMIS

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sensyne Health PLC
LSE:SENS
Cost of Revenue
-£3.2m
CAGR 3-Years
-156%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Renalytix PLC
LSE:RENX
Cost of Revenue
-$2.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Craneware PLC
LSE:CRW
Cost of Revenue
-$26.3m
CAGR 3-Years
-68%
CAGR 5-Years
-45%
CAGR 10-Years
-27%
Intelligent Ultrasound Group PLC
LSE:IUG
Cost of Revenue
-£4.3m
CAGR 3-Years
-29%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Instem PLC
LSE:INS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMIS Group PLC
LSE:EMIS
Cost of Revenue
-£10.9m
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
0%

See Also

What is Sensyne Health PLC's Cost of Revenue?
Cost of Revenue
-3.2m GBP

Based on the financial report for Apr 30, 2021, Sensyne Health PLC's Cost of Revenue amounts to -3.2m GBP.

What is Sensyne Health PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-156%

Over the last year, the Cost of Revenue growth was -258%. The average annual Cost of Revenue growth rates for Sensyne Health PLC have been -156% over the past three years .